Rallybio Corporation

NASDAQ:RLYB

Biotechnology

Healthcare
$15.52 +0.03%

+$0.01 today

Market cap
$83.56M
Beta
-0.88
P/E (TTM)
-11.6
EPS (TTM)
-$1.37
52W Low $2.40High $17.57

Volume 0.04M

Average 0.25M

Private 5-step workspace

Build a RLYB investment thesis

Turn Rallybio Corporation research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.